| Year |
Citation |
Score |
| 2023 |
Newman TM, Wilson AS, Clear KYJ, Tallant EA, Gallagher PE, Cook KL. Probiotic and Muscadine Grape Extract Interventions Shift the Gut Microbiome and Improve Metabolic Parameters in Female C57BL/6 Mice. Cells. 12. PMID 37998334 DOI: 10.3390/cells12222599 |
0.518 |
|
| 2023 |
Klepin HD, Tooze JA, Bitting RL, Davis B, Pleasant K, Melo AC, Cook K, Soto-Pantoja DR, Tallant EA, Gallagher PE. Study design and methods for the pilot study of muscadine grape extract supplement to improve fatigue among older adult cancer survivors (FOCUS) trial. Journal of Geriatric Oncology. 101478. PMID 36990930 DOI: 10.1016/j.jgo.2023.101478 |
0.692 |
|
| 2022 |
Patil PD, Melo AC, Westwood BM, Tallant EA, Gallagher PE. A Polyphenol-Rich Extract from Muscadine Grapes Prevents Hypertension-Induced Diastolic Dysfunction and Oxidative Stress. Antioxidants (Basel, Switzerland). 11. PMID 36290749 DOI: 10.3390/antiox11102026 |
0.309 |
|
| 2020 |
Collard M, Gallagher PE, Tallant EA. A Polyphenol-Rich Extract From Muscadine Grapes Inhibits Triple-Negative Breast Tumor Growth. Integrative Cancer Therapies. 19: 1534735420917444. PMID 32578460 DOI: 10.1177/1534735420917444 |
0.439 |
|
| 2020 |
Rahimi O, Kirby J, Varagic J, Westwood B, Tallant EA, Gallagher PE. Angiotensin-(1-7) reduces doxorubicin-induced cardiac dysfunction in male and female Sprague-Dawley rats through antioxidant mechanisms. American Journal of Physiology. Heart and Circulatory Physiology. 318: H883-H894. PMID 32083974 DOI: 10.1152/Ajpheart.00224.2019 |
0.408 |
|
| 2020 |
Newman T, Wilson A, Tallant E, Gallagher P, Cook K. Intervention with Probiotics and Muscadine Grape Extract Shifts Western Diet-Associated Metabolic, Microbial, and Inflammatory Parameters to Reduce Breast Tumor Growth Current Developments in Nutrition. 4: 344-344. DOI: 10.1093/cdn/nzaa044_043 |
0.583 |
|
| 2020 |
Mackert J, Gallagher P, Tallant E. A Polyphenol-Rich Muscadine Grape Extract Inhibits HER + Breast Cancer and Protects Against Trastuzumab-Induced Cardiotoxicity Current Developments in Nutrition. 4: 334-334. DOI: 10.1093/cdn/nzaa044_033 |
0.312 |
|
| 2020 |
Melo AC, Patil P, Gallagher P, Tallant E. A Polyphenol Rich Muscadine Grape Extract Reduces Macrophage Infiltration in Hypertensive Rat Hearts Associated with a Reduction in Macrophage Migration Current Developments in Nutrition. 4: 52-52. DOI: 10.1093/cdn/nzaa040_052 |
0.325 |
|
| 2019 |
Mackert J, Gallagher PE, Tallant EA. Abstract 1860: Muscadine grape extract prevents proliferation of trastuzumab-sensitive and -resistant HER2 positive breast cancer cells and has synergistic effects when combined with trastuzumab Cancer Research. 79: 1860-1860. DOI: 10.1158/1538-7445.Am2019-1860 |
0.395 |
|
| 2017 |
Wester A, Devocelle M, Tallant EA, Chappell MC, Gallagher PE, Paradisi F. Stabilization of Angiotensin-(1-7) by key substitution with a cyclic non-natural amino acid. Amino Acids. PMID 28744580 DOI: 10.1007/S00726-017-2471-9 |
0.4 |
|
| 2017 |
Gallagher PE, Tallant EA. Abstract 1591: Inhibition of prostate tumor growth by an extract from the muscadine grape Cancer Research. 77: 1591-1591. DOI: 10.1158/1538-7445.Am2017-1591 |
0.422 |
|
| 2017 |
Tallant EA, Deng G, Chen W, Metheny-Barlow LJ, Gallagher PE. Abstract 1227: Angiotensin-(1-7) reduces triple negative breast cancer brain metastatic growth in association with decreased c-Met signaling Cancer Research. 77: 1227-1227. DOI: 10.1158/1538-7445.Am2017-1227 |
0.455 |
|
| 2017 |
Mackert JD, Tallant EA, Gallagher PE. Muscadine Grape Extract Prevents Proliferation of HER2 Positive Breast Cancer Cells in Association with a Decrease in Phosphorylation of AKT and mTOR The Faseb Journal. 31. DOI: 10.1096/Fasebj.31.1_Supplement.646.62 |
0.38 |
|
| 2016 |
Gallagher PE, Gruber KA, Callahan M, Tallant EA. Abstract 1237: Anti-cancer activity of a stable, orally active angiotensin-(1-7) analog Cancer Research. 76: 1237-1237. DOI: 10.1158/1538-7445.Am2016-1237 |
0.492 |
|
| 2015 |
Carver KA, Smith TL, Gallagher PE, Tallant EA. Angiotensin-(1-7) prevents angiotensin II-induced fibrosis in cremaster microvessels. Microcirculation (New York, N.Y. : 1994). 22: 19-27. PMID 25079175 DOI: 10.1111/Micc.12159 |
0.769 |
|
| 2015 |
Deng G, Metheny-Barlow L, Gallagher PE, Tallant EA. Abstract 4981: Angiotensin-(1-7) targets c-Met signaling by up-regulating the phosphatase PTP1b to reduce triple negative breast cancer Cancer Research. 75: 4981-4981. DOI: 10.1158/1538-7445.Am2015-4981 |
0.345 |
|
| 2015 |
Porter BE, Moore JE, Miller MS, Tallant EA, Gallagher PE. Abstract 4563: Muscadine grape extract reduces lung carcinogenesis in female mice exposed to 3-methylcholanthrenein utero Cancer Research. 75: 4563-4563. DOI: 10.1158/1538-7445.Am2015-4563 |
0.389 |
|
| 2015 |
Rahimi OA, Castellino SM, Cammock CE, Tallant EA, Gallagher PE. Abstract 4489: Angiotensin-(1-7) prevents fibrosis in doxorubicin-treated rats Cancer Research. 75: 4489-4489. DOI: 10.1158/1538-7445.Am2015-4489 |
0.42 |
|
| 2015 |
Gallagher PE, Tallant EA. Abstract 2825: Prevention of breast tumor growth by an extract from the muscadine grape Cancer Research. 75: 2825-2825. DOI: 10.1158/1538-7445.Am2015-2825 |
0.422 |
|
| 2014 |
Gallagher PE, Arter AL, Deng G, Tallant EA. Angiotensin-(1-7): a peptide hormone with anti-cancer activity. Current Medicinal Chemistry. 21: 2417-23. PMID 24524765 |
0.393 |
|
| 2013 |
Krishnan B, Smith TL, Dubey P, Zapadka ME, Torti FM, Willingham MC, Tallant EA, Gallagher PE. Angiotensin-(1-7) attenuates metastatic prostate cancer and reduces osteoclastogenesis. The Prostate. 73: 71-82. PMID 22644942 DOI: 10.1002/Pros.22542 |
0.742 |
|
| 2013 |
Krishnan B, Torti FM, Gallagher PE, Tallant EA. Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1. The Prostate. 73: 60-70. PMID 22644934 DOI: 10.1002/Pros.22540 |
0.735 |
|
| 2013 |
Gallagher PE, Arter AL, Soto-Pantoja DR, Tallant EA. Abstract C66: Angiotensin-(1-7) attenuates triple-negative breast cancer growth and progression through regulation of protein phosphatases Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C66 |
0.715 |
|
| 2013 |
Arter AL, Gallagher PE, Tallant EA. Abstract B34: Angiotensin-(1-7) attenuates the proliferation of cancer-associated fibroblasts in triple negative breast cancer Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B34 |
0.47 |
|
| 2012 |
Nautiyal M, Katakam PV, Busija DW, Gallagher PE, Tallant EA, Chappell MC, Diz DI. Differences in oxidative stress status and expression of MKP-1 in dorsal medulla of transgenic rats with altered brain renin-angiotensin system. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 303: R799-806. PMID 22914751 DOI: 10.1152/Ajpregu.00566.2011 |
0.376 |
|
| 2012 |
McCollum LT, Gallagher PE, Tallant EA. Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts. Peptides. 34: 380-8. PMID 22326709 DOI: 10.1016/J.Peptides.2012.01.020 |
0.739 |
|
| 2012 |
Arter AA, Metheny-Barlow L, Gallagher PE, Tallant EA. Abstract 5224: Angiotensin-(1-7) inhibits proliferative and fibrotic signaling mechanisms in triple negative breast cancer Cancer Research. 72: 5224-5224. DOI: 10.1158/1538-7445.Am2012-5224 |
0.498 |
|
| 2012 |
Garcia-Espinosa MA, Lesser GJ, Debinski W, Tallant EA, Gallagher PE. Abstract 1938: Angiotensin-(1-7), a peptide hormone with therapeutic potential for the treatment of glioblastomas Cancer Research. 72: 1938-1938. DOI: 10.1158/1538-7445.Am2012-1938 |
0.301 |
|
| 2011 |
Gallagher PE, Cook K, Soto-Pantoja D, Menon J, Tallant EA. Angiotensin peptides and lung cancer. Current Cancer Drug Targets. 11: 394-404. PMID 21395552 DOI: 10.2174/156800911795538048 |
0.737 |
|
| 2011 |
Diz DI, Arnold AC, Nautiyal M, Isa K, Shaltout HA, Tallant EA. Angiotensin peptides and central autonomic regulation. Current Opinion in Pharmacology. 11: 131-7. PMID 21367658 DOI: 10.1016/J.Coph.2011.02.001 |
0.397 |
|
| 2011 |
Krishnan B, Smith TL, Dubey P, Zapadka ME, Torti FM, Tallant EA, Gallagher PE. Abstract 550: Angiotensin-(1-7) inhibits prostate cancer angiogenesis and metastasis to bone Cancer Research. 71: 550-550. DOI: 10.1158/1538-7445.Am2011-550 |
0.773 |
|
| 2011 |
Gallagher PE, Maglic D, Krishnan B, Castellino SM, Tallant EA. Abstract 5349: Angiotensin-(1-7) inhibits the growth of human pediatric rhabdomyosarcoma in a mouse xenograft model Cancer Research. 71: 5349-5349. DOI: 10.1158/1538-7445.Am2011-5349 |
0.712 |
|
| 2011 |
Tallant EA, Holmes CH, Gallagher PE. Abstract 4220: Inhibition of cancer cell growth by muscadine grape seed and grape skin extracts Cancer Research. 71: 4220-4220. DOI: 10.1158/1538-7445.Am2011-4220 |
0.407 |
|
| 2011 |
Arter AL, Cook KL, Soto-Pantoja DL, Gallagher PE, Tallant EA. Abstract 3274: Molecular mechanisms for the angiotensin-(1-7)-mediated reduction in triple negative breast cancer Cancer Research. 71: 3274-3274. DOI: 10.1158/1538-7445.Am2011-3274 |
0.703 |
|
| 2010 |
Cook KL, Metheny-Barlow LJ, Tallant EA, Gallagher PE. Angiotensin-(1-7) reduces fibrosis in orthotopic breast tumors Cancer Research. 70: 8319-8328. PMID 20837666 DOI: 10.1158/0008-5472.Can-10-1136 |
0.687 |
|
| 2010 |
Varagic J, Ahmad S, Brosnihan KB, Groban L, Chappell MC, Tallant EA, Gallagher PE, Ferrario CM. Decreased cardiac Ang-(1-7) is associated with salt-induced cardiac remodeling and dysfunction Therapeutic Advances in Cardiovascular Disease. 4: 17-25. PMID 19946038 DOI: 10.1177/1753944709353337 |
0.401 |
|
| 2010 |
Calipari ES, Tallant EA, Lesser G, Debinski W, Gallagher PE. Abstract 3575: Angiotensin-(1-7) and temozolomide provide combinatorial inhibition of glioblastoma cell growth Cancer Research. 70: 3575-3575. DOI: 10.1158/1538-7445.Am10-3575 |
0.475 |
|
| 2010 |
Cook KL, Tallant EA, Gallagher PE. Abstract 2273: Angiotensin-(1-7) reduces angiogenesis and fibrosis in orthotopic breast cancer Cancer Research. 70: 2273-2273. DOI: 10.1158/1538-7445.Am10-2273 |
0.701 |
|
| 2010 |
Krishnan B, Gallagher PE, Tallant EA. Abstract 1299: Angiotensin-(1-7) inhibits angiogenesis in human prostate cancer xenografts through an increase in soluble vascular endothelial growth factor receptor 1 (sFLT1) Cancer Research. 70: 1299-1299. DOI: 10.1158/1538-7445.Am10-1299 |
0.747 |
|
| 2009 |
Petty WJ, Miller AA, McCoy TP, Gallagher PE, Tallant EA, Torti FM. Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 7398-404. PMID 19920106 DOI: 10.1158/1078-0432.Ccr-09-1957 |
0.392 |
|
| 2009 |
Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA. Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Molecular Cancer Therapeutics. 8: 1676-83. PMID 19509262 DOI: 10.1158/1535-7163.Mct-09-0161 |
0.739 |
|
| 2009 |
Lesser GJ, Carver KA, Newton SJ, Tallant EA, Gallagher PE. Angiotensin-(1–7), a small molecule inhibitor of glioblastoma growth Journal of Clinical Oncology. 27: 2024-2024. DOI: 10.1200/Jco.2009.27.15_Suppl.2024 |
0.761 |
|
| 2009 |
Petty WJ, Miller AA, McCoy TP, Gallagher PE, Tallant EA, Torti FM. Abstract B208: Phase I study of angiotensin‐(1–7), an endogenous antiangiogenic hormone: Clinical, pharmacokinetic, and biomarker findings Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-B208 |
0.321 |
|
| 2008 |
Petty WJ, Miller AA, McCoy TP, Gallagher PE, Tallant EA, Torti FM. Phase I trial of angiotensin-(1-7): An endogenous anti-angiogenic hormone. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 14591. PMID 27950087 DOI: 10.1200/jco.2008.26.15_suppl.14591 |
0.422 |
|
| 2008 |
Gallagher PE, Ferrario CM, Tallant EA. Regulation of ACE2 in cardiac myocytes and fibroblasts American Journal of Physiology - Heart and Circulatory Physiology. 295: H2373-H2379. PMID 18849338 DOI: 10.1152/Ajpheart.00426.2008 |
0.45 |
|
| 2008 |
Gallagher PE, Ferrario CM, Tallant EA. MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides American Journal of Physiology - Cell Physiology. 295: C1169-C1174. PMID 18768926 DOI: 10.1152/Ajpcell.00145.2008 |
0.446 |
|
| 2007 |
Menon J, Soto-Pantoja DR, Callahan MF, Cline JM, Ferrario CM, Tallant EA, Gallagher PE. Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Research. 67: 2809-15. PMID 17363603 DOI: 10.1158/0008-5472.Can-06-3614 |
0.72 |
|
| 2006 |
Tallant EA, Ferrario CM, Gallagher PE. Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart. Future Cardiology. 2: 335-42. PMID 19804091 DOI: 10.2217/14796678.2.3.335 |
0.404 |
|
| 2006 |
Whaley-Connell AT, Chowdhury NA, Hayden MR, Stump CS, Habibi J, Wiedmeyer CE, Gallagher PE, Tallant EA, Cooper SA, Link CD, Ferrario C, Sowers JR. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat. American Journal of Physiology. Renal Physiology. 291: F1308-14. PMID 16788142 DOI: 10.1152/Ajprenal.00167.2006 |
0.33 |
|
| 2006 |
Jessup JA, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Chappell MC, Ferrario CM. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats American Journal of Physiology - Heart and Circulatory Physiology. 291: H2166-H2172. PMID 16766648 DOI: 10.1152/Ajpheart.00061.2006 |
0.427 |
|
| 2006 |
Gallagher PE, Chappell MC, Ferrario CM, Tallant EA. Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. American Journal of Physiology. Cell Physiology. 290: C420-6. PMID 16176966 DOI: 10.1152/Ajpcell.00409.2004 |
0.422 |
|
| 2005 |
Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Tallant EA, Smith RD, Chappell MC. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors Kidney International. 68: 2189-2196. PMID 16221218 DOI: 10.1111/J.1523-1755.2005.00675.X |
0.405 |
|
| 2005 |
Tallant EA, Ferrario CM, Gallagher PE. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. American Journal of Physiology. Heart and Circulatory Physiology. 289: H1560-6. PMID 15951342 DOI: 10.1152/Ajpheart.00941.2004 |
0.452 |
|
| 2005 |
Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2 Circulation. 111: 2605-2610. PMID 15897343 DOI: 10.1161/Circulationaha.104.510461 |
0.406 |
|
| 2004 |
Richmond RS, Tallant EA, Gallagher PE, Ferrario CM, Strawn WB. Angiotensin II stimulates arachidonic acid release from bone marrow stromal cells. Journal of the Renin-Angiotensin-Aldosterone System : Jraas. 5: 176-82. PMID 15803435 DOI: 10.3317/Jraas.2004.037 |
0.366 |
|
| 2004 |
Gallagher PE, Tallant EA. Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis. 25: 2045-52. PMID 15284177 DOI: 10.1093/Carcin/Bgh236 |
0.506 |
|
| 2004 |
Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM. Upregulation of Angiotensin-Converting Enzyme 2 after Myocardial Infarction by Blockade of Angiotensin II Receptors Hypertension. 43: 970-976. PMID 15007027 DOI: 10.1161/01.Hyp.0000124667.34652.1A |
0.368 |
|
| 2003 |
Tallant EA, Clark MA. Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7) Hypertension. 42: 574-579. PMID 12953014 DOI: 10.1161/01.Hyp.0000090322.55782.30 |
0.462 |
|
| 2003 |
Clark MA, Tallant EA, Tommasi E, Bosch S, Diz DI. Angiotensin-(1-7) reduces renal angiotensin II receptors through a cyclooxygenase-dependent mechanism. Journal of Cardiovascular Pharmacology. 41: 276-83. PMID 12548089 DOI: 10.1097/00005344-200302000-00017 |
0.428 |
|
| 2001 |
Clark MA, Diz DI, Tallant EA. Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells. Hypertension. 37: 1141-6. PMID 11304516 DOI: 10.1161/01.Hyp.37.4.1141 |
0.442 |
|
| 2001 |
Clark MA, Tallant EA, Diz DI. Downregulation of the AT1A receptor by pharmacologic concentrations of Angiotensin-(1-7). Journal of Cardiovascular Pharmacology. 37: 437-48. PMID 11300657 DOI: 10.1097/00005344-200104000-00011 |
0.324 |
|
| 1999 |
Tallant EA, Diz DI, Ferrario CM. State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension. 34: 950-7. PMID 10523390 DOI: 10.1161/01.Hyp.34.4.950 |
0.454 |
|
| 1999 |
Strawn WB, Ferrario CM, Tallant EA. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension. 33: 207-11. PMID 9931106 DOI: 10.1161/01.Hyp.33.1.207 |
0.428 |
|
| 1998 |
Brosnihan KB, Li P, Tallant EA, Ferrario CM. Angiotensin-(1-7): a novel vasodilator of the coronary circulation. Biological Research. 31: 227-34. PMID 9830510 |
0.308 |
|
| 1997 |
Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counterregulatory actions of angiotensin-(1-7). Hypertension. 30: 535-41. PMID 9322978 DOI: 10.1161/01.Hyp.30.3.535 |
0.433 |
|
| 1997 |
Tallant EA, Higson JT. Angiotensin II activates distinct signal transduction pathways in astrocytes isolated from neonatal rat brain. Glia. 19: 333-42. PMID 9097077 DOI: 10.1002/(Sici)1098-1136(199704)19:4<333::Aid-Glia6>3.0.Co;2-Y |
0.393 |
|
| 1996 |
Tallant EA, Diz DI, Ferrario CM. Identification of AT1 receptors on cultured astrocytes. Advances in Experimental Medicine and Biology. 396: 121-9. PMID 8726692 DOI: 10.1007/978-1-4899-1376-0_13 |
0.364 |
|
| 1996 |
Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension. 28: 104-8. PMID 8675248 DOI: 10.1161/01.Hyp.28.1.104 |
0.457 |
|
| 1995 |
Freeman EJ, Ferrario CM, Tallant EA. Angiotensins differentially activate phospholipase D in vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats. American Journal of Hypertension. 8: 1105-11. PMID 8554734 DOI: 10.1016/0895-7061(95)00221-A |
0.423 |
|
| 1995 |
Chappell MC, Jacobsen DW, Tallant EA. Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells. Peptides. 16: 741-7. PMID 7479311 DOI: 10.1016/0196-9781(95)00044-K |
0.364 |
|
| 1994 |
Freeman EJ, Tallant EA. Vascular smooth-muscle cells contain AT1 angiotensin receptors coupled to phospholipase D activation. The Biochemical Journal. 304: 543-8. PMID 7998990 DOI: 10.1042/bj3040543 |
0.314 |
|
| 1991 |
Jaiswal N, Tallant EA, Diz DI, Khosla MC, Ferrario CM. Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension. 17: 1115-20. PMID 2045158 DOI: 10.1161/01.Hyp.17.6.1115 |
0.303 |
|
| 1991 |
Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM. The nonpeptide angiotensin II antagonist DuP 753 is a potent stimulus for prostacyclin synthesis. American Journal of Hypertension. 4: 228-33. PMID 2043299 DOI: 10.1093/Ajh/4.3.228 |
0.38 |
|
| 1990 |
Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line. Peptides. 11: 375-80. PMID 2162536 DOI: 10.1016/0196-9781(90)90095-M |
0.321 |
|
| Show low-probability matches. |